BeStock  
Stocks › Biotechnology › CLYM

Climb Bio CLYM

US equityMarket cap rank #3605Biotechnology
$10.71 +$0.03 (+0.28%)
Pre-market · Oct 8, 9:10 am ET · After hours $10.71 0.00%
Open$10.43
Prev close$10.68
Day range$10.34 – $10.95
Volume755.8K
Market cap$615.14M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership109.8%+2.43 pts vs. prior quarter
Institutions holding132+4 vs. prior quarter
Insider trades (recent)38 buys / 11 sellsNet buying
Short interest14.81% of floatDays to cover 4.5 · as of 15 Sep 2026
Short-sale volume share20.5%5-day average of daily volume

Short-sale volume as % of daily volume

12%17%22%27%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$554.4K (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

−$2.1MSuper+$1.6MBig+$507.2KMid+$207.6KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 53.5% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.21.83%
  • FMR11.82%
  • Pontifax Venture Capital9.06%
  • UBS Asset Management5.93%
  • Braidwell LP4.87%
  • Adage Capital Management, L.P.4.36%
  • BlackRock4.10%
  • T. Rowe Price Group, Inc.3.70%

By investor type

  • Mutual Fund43.72%
  • VC/PE Fund34.61%
  • Hedge Fund29.89%
  • Individual/Insider1.65%
  • Public Company0.89%
  • Private Company0.45%
  • Insurance Company0.14%
  • Government Pension Fund0.07%

Reported short interest has risen from 8.90% to 14.81% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +1,239,063 21.8%
Stephen Thomas Individual/Insider 2026/Q3 +313,312 0.8%
FMR Mutual Fund 2026/Q3 +6,783,967 11.8%
UBS Asset Management Mutual Fund 2026/Q3 +3,318,921 5.9%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +2,506,000 4.4%
Cormorant Asset Management, LP Hedge Fund 2026/Q3 +2,106,000 3.7%
BlackRock Mutual Fund 2026/Q3 +1,953,223 4.1%
Frontier Capital Management Mutual Fund 2026/Q3 +1,939,019 3.4%
Woodline Partners LP Hedge Fund 2026/Q3 +1,582,291 2.8%
Braidwell LP Hedge Fund 2026/Q3 +1,267,700 4.9%
Redmile Group, LLC Hedge Fund 2026/Q3 +1,226,330 2.1%
Citadel Advisors LLC Hedge Fund 2026/Q3 +952,309 2.3%
StemPoint Capital LP Hedge Fund 2026/Q3 +742,745 1.3%
Parkman Healthcare Partners LLC Hedge Fund 2026/Q3 +563,484 1.0%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +556,376 3.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
27 Sep 2026 Andrew Levin Principal Financial Officer & Executive Chairman Derivative Exercise and Retained +70,000 $7.89 70,000
14 Sep 2026 Stephen Thomas Director Automatic Disposition -100,000 $13.67 467,969
28 Jun 2026 RA Capital Management, L.P. Other Derivative Acquisition +70,284 $13.36 70,284
28 Jun 2026 Aoife Brennan Chief Executive Officer Intent to Sell (Form 144) -30,902 $13.17 –
28 Jun 2026 Aoife Brennan Chief Executive Officer Derivative Exercise and Sale -30,902 $13.17 87,731
26 Jun 2026 Aoife Brennan Chief Executive Officer Derivative Exercise and Retained +37,848 – 87,731
4 Jun 2026 Douglas Williams Chair of Board Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Kimberlee Drapkin Independent Director Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 RA Capital Management, L.P. Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Andrew Levin Principal Financial Officer & Executive Chairman Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Alexander Cumbo Independent Director Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Stephen Thomas Director Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Judith Dunn Independent Director Other Derivative Acquisition +40,000 $10.55 40,000
28 Apr 2026 RA Capital Management, L.P. Other Derivative Acquisition +2,106,000 $0.00 22,546,000
25 Feb 2026 Stephen Thomas Director Automatic Disposition -50,000 $7.01 154,657
24 Feb 2026 Stephen Thomas Director Intent to Sell (Form 144) -50,000 $6.36 –
12 Feb 2026 Stephen Thomas Director Automatic Disposition -100,000 $5.81 204,657
11 Feb 2026 Stephen Thomas Director Intent to Sell (Form 144) -100,000 $5.56 –
5 Jan 2026 Cindy Driscoll Officer Other Derivative Acquisition +100,000 $3.81 100,000
5 Jan 2026 Aoife Brennan Chief Executive Officer Other Derivative Acquisition +700,000 $3.81 700,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 8,508,354 14.8% 4.5
31 Aug 2026 7,300,939 12.7% 5.9
14 Aug 2026 7,557,264 13.2% 6.3
31 Jul 2026 7,037,695 12.3% 6.8
15 Jul 2026 6,871,210 12.0% 5.1
30 Jun 2026 5,096,670 8.9% 3.0

Discussion

No comments yet — be the first to weigh in on CLYM.

Leave a comment

Scroll to Top